3 Best Performing Biotech Funds So Far In 2019

This Zacks sector – Health product has a history of positive total returns for more than 10 years.

FBIOX carries a Zacks Rank #1 and has an annual expense ratio of 0.72%, which is below the category average of 1.27%. It has returned 15.4% on a year-to-date basis. FBIOX has no minimum initial investment.

T. Rowe Price Health Sciences Fund (PRHSX - Free Report) aims for capital appreciation. The fund invests majority of its assets in common stocks of companies that pursue research, development, production or distribution of products or services related to health care, medicine or the life sciences. PRHSX is a non-diversified fund.

This Zacks sector – Health product has a history of positive total returns for more than 10 years.

PRHSX carries a Zacks Rank #1 and has an annual expense ratio of 0.77%, which is below the category average of 1.26%. It has returned 15.6% on a year-to-date basis. PRHSX has a minimum initial investment of $2500.

Janus Henderson Global Life Sciences Fund Class A (JFNAX - Free Report) aims for long-term capital growth. The fund invests majority of its assets in securities of companies that the portfolio managers consider to have a life science orientation.

This Zacks sector – Health product has a history of positive total returns for more than 10 years.

JFNAX carries a Zacks Rank #2 and has an annual expense ratio of 0.99%, which is below the category average of 1.27%. It has returned 14.3% on a year-to-date basis. JFNAX has a minimum initial investment of $2500.

1 2 3
View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any specific ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.